ChEMBL logo

ChEMBL

spacer
ChEMBL Statistics
  Loading Statistics...
spacer

Compound Report Card

Compound Name and Classification

Compound ID CHEMBL2007641
CHEMBL2007641
Compound Name PERTUZUMAB
ChEMBL Synonyms RG-1273 | Omnitarg Perjeta | Rhumab-2C4 | Pertuzumab
Max Phase 4 (Approved)
Trade Names Omnitarg Perjeta

Mechanism of Action

Mechanism of Action ChEMBL Target References
Receptor protein-tyrosine kinase erbB-2 inhibitor Receptor protein-tyrosine kinase erbB-2 DailyMed

Molecule Features

CHEMBL2007641 compound icon
Drug Type:mAB Rule of Five:N First In Class:N Chirality:Single Stereoisomer Prodrug:N Oral:N Parenteral:Y Topical:N Black Box:Y Availability Type:Prescription-only

Clinical Data

Number of clinical trials registered at clinicaltrials.gov
Number of reviews at The Cochrane Collaboration
Number of entries at British National Formulary

Compound Cross References

ATC L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 - ANTINEOPLASTIC AGENTS
L01X - OTHER ANTINEOPLASTIC AGENTS
L01XC - Monoclonal antibodies
L01XC13 - pertuzumab

ChemSpider ChemSpider Identifier not yet assigned
DailyMed pertuzumab
Wikipedia Pertuzumab
spacer
spacer